Panacea Biotec is currently trading at Rs. 136.75, up by 10.45 points or 8.34% from its previous closing of Rs. 125.25 on the BSE.

The scrip opened at Rs. 121.80 and has touched a high and low of Rs. 138.90 and Rs. 121.00 respectively. So far 24658 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 219.00 on 27-Feb-2019 and a 52 week low of Rs. 111.00 on 16-Dec-2019.

Last one week high and low of the scrip stood at Rs. 138.90 and Rs. 111.00 respectively. The current market cap of the company is Rs. 806.98 crore.

The promoters holding in the company stood at 73.59%, while Institutions and Non-Institutions held 1.80% and 24.61% respectively.

Panacea Biotec has received awards worth $24.32 million from U.N. Agencies (UNICEF and PAHO) for supply of its Easyfive-TT, a fully liquid WHO prequalified wP based Pentavalent Vaccine (DTwPHepB-Hib). UNICEF award is for calendar year 2020 and award of PAHO is for three calendar years i.e. 2020-2022. Easyfive-TT was introduced by the company as world's first fully liquid wP-based pentavalent vaccine in Indian market in 2005.

Panacea Biotec is a leading research based Biotechnology Company with established research, manufacturing and marketing capabilities.

Panacea Biotec Share Price

133.95 -1.75 (-1.29%)
14-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1545.25
Dr. Reddys Lab 5861.00
Cipla 1356.95
Zydus Lifesciences 984.75
Lupin 1635.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.